Their results indicate that elevated CypA leads to doxorubicin and vincristine resistance in SK-Hep1 cell lines in drug sensitivity and drug accumulation assays, suggesting that CypA may facilitate tumor cells to survive, even in unfavorable environments such as hypoxia and chemotherapy. Here, PPIA is linked to neoplasm.